Robotic Minimally Invasive Inguinal Hernia Repair With Dexter
RAS-Ahead
1 other identifier
observational
50
3 countries
3
Brief Summary
This study aims to confirm the perioperative and early postoperative safety and clinical performance (efficacy) of the Dexter Robotic System, in patients undergoing primary transperitoneal unilateral or bilateral inguinal hernia repair.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jun 2023
Shorter than P25 for all trials
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 15, 2023
CompletedFirst Posted
Study publicly available on registry
May 24, 2023
CompletedStudy Start
First participant enrolled
June 2, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 23, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
October 23, 2023
CompletedJanuary 5, 2024
January 1, 2024
5 months
May 15, 2023
January 3, 2024
Conditions
Outcome Measures
Primary Outcomes (2)
Safety: occurrence of serious (Clavien - Dindo grades III-V), device-related, adverse events
perioperatively up to 30 days
Performance: successful completion of the Dexter-assisted procedure, i.e. free of any conversion to an open or fully laparoscopic surgical approach
intraoperative
Interventions
Primary transperitoneal unilateral or bilateral inguinal hernia repair with the Dexter robotic system
Eligibility Criteria
adult patients undergoing primary transperitoneal unilateral or bilateral inguinal hernia repair
You may qualify if:
- Aged \> 18 years
- Patients planned to undergo elective robot-assisted and laparoscopic surgery for primary unilateral or bilateral inguinal hernia repair using one camera port, two ports for the manipulating instruments, and additional ports as needed.
- Able to provide Informed Consent according to local regulation
You may not qualify if:
- Morbidly obese patients (BMI \> 40)
- Any relative and absolute contraindications for the use of conventional endoscopes and endoscopic surgical instruments
- Need for robotic stapling, advanced energy delivery, ultrasound, cryoablation and microwave energy delivery
- Bleeding diathesis
- Pregnancy
- Patients with pacemakers or internal defibrillators
- Any planned concomitant procedures
- Patient deprived of liberty by administrative or judicial decision or under legal guardianship
- Participation in another interventional clinical trial
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Distalmotion SAlead
- Confiniscollaborator
Study Sites (3)
Centre Hospitalier de Saintes
Saintes, France
UKSH Kiel
Kiel, 24105, Germany
Kantonspital Winterthur
Winterthur, Switzerland
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 15, 2023
First Posted
May 24, 2023
Study Start
June 2, 2023
Primary Completion
October 23, 2023
Study Completion
October 23, 2023
Last Updated
January 5, 2024
Record last verified: 2024-01
Data Sharing
- IPD Sharing
- Will not share